Interventions to Prevent Vasovagal Reactions among Blood Donors Donating blood is considered safe. Vasovagal reactions, however, occur fairly often and may lead to lower rates of donor retention… February 17, 2026
Nipocalimab for Severe Hemolytic Disease of the Fetus and Newborn Hemolytic disease of the fetus and newborn (HDFN) often results in severe anemia resulting in intrauterine transfusions and increased risk… February 12, 2026
Pediatric Platelet Transfusion Practices in the U.S. The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P) program links blood donors to pediatric transfusion recipients to study vein-to-vein associations… February 4, 2026
Clinical Guidelines for Anemia and Chronic Kidney Disease The Kidney Disease: Improving Global Outcomes (KDIGO) committee has updated their 2012 guidelines for the management of anemia in patients… January 28, 2026
CD19 CAR T-Cell Therapy—A Potential Treatment for Patients with Refractory Autoimmune Hemolytic Anemia A significant proportion of patients with autoimmune hemolytic anemia (AIHA) become refractory to available treatments. Researchers in China are now… January 23, 2026
Ferritin-Guided Donation Policies Decrease Iron Deficiency Most blood establishments monitor hemoglobin (Hb) levels to prevent anemia, but Hb monitoring does not protect against iron deficiency (ID)…. January 14, 2026
RBC Transfusions to Treat Acute Heavy Menstrual Bleeding About one in four women of reproductive age experience uncomfortable and painful heavy menstrual bleeding. For some women, the pain… January 7, 2026
RBC Transfusion Outcomes Similar in ICU Patients with and Without Cardiovascular Disease In intensive care units (ICU), 25%-50% of patients receive RBC transfusions. Up to 30-40% of ICU patients also have a… January 7, 2026
